A five-year field assessment of rapid diagnostic tests for meningococcal meningitis in Niger by using the combination of conventional and real-time PCR assays as a gold standard

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 1, 2014, Pages 6-12

  Collard, Jean Marc ^a,d   Wang, Xin ^b   Mahamane, Ali Elhaj ^a   Idi, Issa ^a   Issaka, Bassira ^a   Ousseni, Moumouni ^a   Mayer, Leonard W ^b   Nato, Farida ^c   Moulia Pelat, Jean Paul ^a  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c INSTITUT PASTEUR   (France)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Early detection; Meningitis; Neisseria meningitidis serogroups A and W; Niger; Patient treatment; Rapid diagnostic tests

Indexed keywords

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; GOLD STANDARD; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MENINGITIS; NEISSERIA MENINGITIDIS; NIGER; NONHUMAN; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAFF TRAINING;

EARLY DETECTION; MENINGITIS; NEISSERIA MENINGITIDIS SEROGROUPS A AND W; NIGER; PATIENT TREATMENT; RAPID DIAGNOSTIC TESTS;

ANTIGENS, BACTERIAL; HUMANS; MENINGITIS, MENINGOCOCCAL; NIGER; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84891338354     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt104     Document Type: Article

References (29)

1. WHO. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Wkly Epidemiol Rec 2010;85:47-63.
2. Daugla D, Gami J, Gamougam K et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet 2013 pii: S0140-6736(13)61612-8. doi:10.1016/S0140-6736(13)61612-8. [Epub ahead of print].
3. Collard JM, Maman Z, Yacouba H et al. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis 2010;16:1496-8.
4. Xie O, Pollard A, Mueller JE, Norheim G. Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine. Vaccine 2013;31:2852-61.
5. Chanteau S, Dartevelle S, Mahamane AE et al. New rapid diagnostic tests for Neisseria meningitidis serogroups A, C, W135 and Y. PLoS Med 2006;3:1579-86.
6. Boisier P, Mahamane AE, Hamidou AA et al. Field evaluation of rapid diagnostic tests for meningococcal meningitis in Niger. Trop Med Int Health 2009;14:111-7.
7. Rose AM, Gerstl S, Mamane AE et al. Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger. Plos One 2009;4:e7326.
8. Rose AM, Mueller JE, Gerstl S et al. Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS One. 2010;5:e11086.
9. Terrade A, Collard JM, Nato F, Taha MK. Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A. Trans R Soc Trop Med Hyg 2013;107:460-1.
10. Wu HM, Cordeiro SM, Harcourt BH et al. Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis. BMC Infect Dis 2013;13:26.
11. Dolan Thomas J, Hatcher CP, Satterfield DA et al. sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One 2011;6:e19361.
12. WHO. Control of Epidemic Meningococcal Disease. Document WHO/ EMC/BAC/98.3. Geneva: World Health Organization; 1998. http:// www.who.int/csr/resources/publications/meningitis/whoemcbac983. pdf [accessed 3 June 2013].
13. Chanteau S, Sidikou F, Djibo S et al. Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Trans R Soc Trop Med Hyg 2006;100:677-80.
14. Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000;38:855-7.
15. Mothershed EA, Sacchi CT, Whitney AM et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 2004;42:320-8.
16. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
17. Cohen J. A coefficient of agreement for nominal scale. Educat Psychol Meas 1960;20:37-46.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977:33:159-74.
19. Fleiss JL Statistical methods for rates and proportions. New York: John Wiley and Sons; 1981.
20. Wang X, Theodore MJ, Mair R et al. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol 2012;50:702-8.
21. Higa FT, Fukasawa LO, Gonçalves MG et al. Use of sodCversus ctrA for realtimepolymerase chain reaction-based detection of Neisseriameningitidis in sterile body fluids. Mem Inst Oswaldo Cruz 2013;108:246-7.
22. Nakamichi K, Kurane I, Saijo M. Evaluation of a quantitative real-time PCR assay for the detection of JC polyomavirus DNA in cerebrospinal fluid without nucleic acid extraction. Jpn J Infect Dis 2011;64:211-6.
23. Djibo S, Njanpop Lafourcade BM, Boisier P et al. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135. Trans R Soc Trop Med Hyg 2006;100:573-8.
24. World Health Organization, Inter country Support Team - West Africa Weekly feedback bulletin on cerebrospinal meningitis. Epidemiological situation of week 49-52; From 03 to 30 December 2012 http://www. meningvax.org/files/BulletinMeningite2012_S49_52.pdf [accessed 3 June 2013].
25. Yansouni CP, Bottieau E, Lutumba P et al. Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis 2013;13:546-58.
26. WHO. Standardized treatment of bacterial meningitis in Africa in epidemic and non epidemic situations. Geneva: World Health Organization; 2007. WHO/CDS/EPR/2007.3. http://www.who.int/ entity/csr/resources/publications/meningitis/WHO_CDS_EPR_2007_3. pdf [accessed 3 June 2013].
27. Molyneux E, Nizami SQ, Saha S et al. 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study. Lancet. 2011;377:1837-45.
28. Amouzou A, Habi O, Bensaïd K, Niger Countdown Case Study Working Group. Reduction in child mortality in Niger: a countdown to 2015 country case study. Lancet 2012;380:1169-78.
29. Jusot JF, Tohon Z, Yazi AA, Collard JM. Significant sequelae after bacterial meningitis in Niger: a cohort study. BMC Infect Dis 2013;13:228.